Edmonton-based GLC tests new generation at airport
It has been decided that Edmonton International Airport is the exclusive location to verify a new COVID-19 control that can produce effects in seconds.
In partnership with GLC Medical (GLCM) Inc. , a subsidiary of Graphene Leaders Canada (GLC) Inc. , a company based in Edmonton, EIA will host clinical trials of this new generation that has the prospect of having global implications for COVID-19. This check is performed with a portable unit that takes a saliva pattern from a user and tells them if someone has COVID-19 in less than a minute, compared to other checks with longer wait times in the lab for results. promises many benefits ranging from its ease of use to the removal of the nasal swab by direct virus detection. This type of control will help meet the need for a 14-day quarantine era in Canada and, in all likelihood, other foreign quarantine restrictions. or cutting this barrier can help travelers feel safer when they return to the trip.
GLC Medical (GLCM) Inc. is headquartered in Edmonton Research Park and has attracted foreign attention from the progression of this test, which is still undergoing clinical trials as a component of the regulatory approval procedure with fitness authorities. As an airport, the EIA includes running with governments and within a regulated structure. With safe and secure amenities and passenger consistency, this is one of the reasons why an airport is a wonderful position to start testing the testing phase of this new immediate COVID-19 test.
“We all need to travel to get back to the general and rapid COVID-19 verification will drive this return while strengthening passenger confidence in protecting our industry. Although we have experienced some expansion in recent months, our number of COVID 19 passengers remain low and such control is very important for our future. All airlines, airports and the entire travel and hospitality sector are looking for this solution. That’s exactly what we’re going to do. This is an exciting opportunity for all of us. “
-Tom Ruth, President and CEO, Edmonton International Airport
“We are very pleased to offer the world an immediate advanced solution to graphene for the detection of the COVID-19 virus. The opportunity to work with EIA, a world-renowned airport authority, to enable and unite families is very important. This immediate and advanced graphene control demonstrates the strength of graphene innovation to succeed over the demanding situations of COVID-19. GLC is proud to be a component of the EIA initiative to establish global popularity in terms of protection and reliability for its users. “
-Donna Mandau, President and CEO of Graphene Leaders Canada (GLC) Inc. / GLC Medical (GLCM) Inc.
How it works
The user who is being educated provides a saliva pattern in the unit;
The graphene surface of the control unit is designed to bind to the complex protein of the virus;
This binding occasion adjusts the electronic characteristics of graphene, and this measurable replacement is what is used to determine whether a user is inflamed or not;
The device will display a soft red or green tone in less than a minute to imply that the user is virus-free or not;
Control should not be administered through a fitness professional and, with training, can be administered through anyone, in the same way as basic first aid training.
The next step is to take this check and the GLC to the EIA and identify a secure check site. Check details and procedure will be shared in the coming weeks. A start date has not been set, but once started, the clinical trial will last several weeks this fall. This trial phase will help GLC Medical download regulatory approval and certification of its controls from Health Canada and other regulators, as well as the United States and other parts of the world.
As a non-profit company, EIA strives to attract investment and jobs to Edmonton’s metropolitan domain and help local innovation. Airports connect global communities and create opportunities for other people and businesses. The partnership with GLC Medical provides excellent opportunities to have an effect in many industries beyond the travel industry. EIA focuses on protection and security as the number one basic price and creating safe fun for passengers at the airport is a priority. research and adoption of new inventions and technologies to help passengers feel comfortable at the airport and travel in general. The recent announcement of EIA accreditation through the Airports International Council (ACI) with airport fitness certification is another example of how the EIA does protection and security is a very sensible priority in the creation of a safe airport. Visit flyeia. com/ready for more information.
About Edmonton International Airport
Edmonton International Airport is a self-funded non-profit corporation mandated to publicize economic prosperity in the Edmonton area. The EIA is Canada’s fifth-most active airport in terms of passenger traffic and Canada’s largest airport across the area. -stop flights to destinations in Canada, the United States, Mexico, the Caribbean and Europe. The EIS is a major economic engine, with an economic production of more than $3. 2 billion, which supports more than 26,000 jobs. For more information, visit: flyeia. com, @flyeia on Twitter, Instagram, Linkedin or Facebook.
About GLC
Graphene Leaders Canada (GLC) Inc. es a Canadian generation company that produces high purity Graphene Array nanotejids that serve as a platform generation with the ability to raise prices to many applications. Graphene Leaders Canada Inc. se strives to work with the industry to expand responses. through the integration of graphene to expand new cutting-edge products. GLC Medical (GLCM) Inc. es a subsidiary of GLC Inc. and provides responses to graphene in the medical industry by leveraging our expertise in tissue science to paint with graphene and expand products and responses. serve the well-being of other people and the planet.
See the edition in businesswire. com: https://www. businesswire. com/news/home/20200924005164/fr/
contacts
Media: Darrell Winwood Corporate and Digital Communications Edmonton International Airport: 587-338-4454dwinwood@flyeia. com Donna MandauPresident and CEOGraphene Leaders Canada (GLC) Inc. GLC Medical (GLCM) Inc. c: 780-984-4737th: dmandau glcplus. com